MiMedx Group, Inc (MDXG)
MiMedx Group, Inc. is a healthcare company specializing in the development and commercialization of regenerative biomaterial products derived from human placental tissues. The company's products are used in wound care, orthopedics, and surgery to promote healing and tissue regeneration. MiMedx focuses on innovative biologic therapeutics supported by regenerative medicine research and has established a presence in healthcare markets worldwide.
Company News
MiMedx Group will showcase its advanced wound care portfolio at the Symposium on Advanced Wound Care Fall meeting in Las Vegas, presenting six clinical and scientific posters focused on wound healing technologies and treatments.
The chronic wound care market is expected to grow at a CAGR of 4.17% from 2024 to 2031, driven by the high prevalence of chronic diseases and advancements in wound care technologies. The market is segmented by product, application, end-user, and region, with North America leading due to its developed healthcare infrastructure.
Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify.
The company released data for two drug programs and missed its goals on both.